Sector
Health & Life Sciences
Market context — pending partner input
Sector-specific market context for health & life sciences has not yet been drafted. This section needs partner input before publishing — it should cover the regulatory landscape, typical client profile, and where FAP’s services apply within this sector.
Related Track Record
Accounting Support Services to a health marketing company in Uganda
- Service
- Performance Improvement
- Sector
- Health & Life Sciences
- Year
- 2026
Financial Management Consultancy Services
- Service
- Performance Improvement
- Sector
- Health & Life Sciences
- Year
- 2025/2026
Financial Accountancy Services
- Service
- Performance Improvement
- Sector
- Health & Life Sciences
- Year
- 2026
Feasibility study and Business Plan for a $1b-dollar pharmaceutical manufacturing plant.
- Service
- Corporate Finance
- Sector
- Health & Life Sciences
- Year
- 2024/2025
Project Pearl – USD5m sell-side transaction advisory for a leading private hospital.
- Service
- Corporate Finance
- Sector
- Health & Life Sciences
- Year
- 2024-2025
Detailed market study on the medical/hospital sector in Rwanda focussing on maternal and child health.
- Service
- Corporate Finance
- Sector
- Health & Life Sciences
- Year
- 2024
Business Plan relating to a $5m dollar capital raise geared towards value-chain expansion.
- Service
- Corporate Finance
- Sector
- Health & Life Sciences
- Year
- 2021/2022
Project Maziwa – Limited TA services for a $70m capital raise
- Service
- Corporate Finance
- Sector
- Health & Life Sciences
- Year
- 2022
$3.5m capital raise for a greenfield syringe manufacturing plant in Uganda.
- Service
- Corporate Finance
- Sector
- Health & Life Sciences
- Year
- 2021
| Client | Mandate | Service | Sector | Year |
|---|---|---|---|---|
| Amari Health | Accounting Support Services to a health marketing company in Uganda | Performance Improvement | Health & Life Sciences | 2026 |
| Confidential | Financial Management Consultancy Services | Performance Improvement | Health & Life Sciences | 2025/2026 |
| MedOptics | Financial Accountancy Services | Performance Improvement | Health & Life Sciences | 2026 |
| Dei BioPharma | Feasibility study and Business Plan for a $1b-dollar pharmaceutical manufacturing plant. | Corporate Finance | Health & Life Sciences | 2024/2025 |
| Le Memorial | Project Pearl – USD5m sell-side transaction advisory for a leading private hospital. | Corporate Finance | Health & Life Sciences | 2024-2025 |
| Hitech Engineering FZE | Detailed market study on the medical/hospital sector in Rwanda focussing on maternal and child health. | Corporate Finance | Health & Life Sciences | 2024 |
| PDMS | Business Plan relating to a $5m dollar capital raise geared towards value-chain expansion. | Corporate Finance | Health & Life Sciences | 2021/2022 |
| BetaKoreb | Project Maziwa – Limited TA services for a $70m capital raise | Corporate Finance | Health & Life Sciences | 2022 |
| Mahathi Medical | $3.5m capital raise for a greenfield syringe manufacturing plant in Uganda. | Corporate Finance | Health & Life Sciences | 2021 |